CCL5 has been found to be upregulated in the airways and sputum of COPD patients during exacerbations [37], while CXCL10 levels have been seen to be elevated in the lungs of COPD patients [38]. This evidence concerns the gene CXCL10 and chronic obstructive pulmonary disease.